AcquisitionOther
Paratek Pharmaceuticals, Inc. acquired Paratek Pharmaceuticals, Inc
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Paratek Pharmaceuticals, Inc. -> Paratek Pharmaceuticals, Inc · $2.15
Gurnet Point primarily focuses on businesses that have high growth potential in the late product development and commercialization stages of their evolution.
Open source record (SEC) ↗